Theranexus (EPA:ALTHX) | WebDisclosure

PRESS RELEASE

published on 11/19/2024 at 18:00, 1 year 2 months ago

Theranexus fait le point sur son programme Batten-1 dans la maladie de Batten CLN3
Présentation des résultats prometteurs de l'essai de phase I/II de Batten-1 par Theranexus et BBDF lors du Child Neurology Society Annual Meeting. Signaux positifs sur l'acuité visuelle de patients atteints de CLN3

Essai Clinique Theranexus Maladie De Batten CLN3 BBDF Acuité Visuelle
PRESS RELEASE

published on 11/19/2024 at 18:00, 1 year 2 months ago

Update on the Theranexus' Batten-1 project in CLN3 Batten's disease
Theranexus and BBDF present positive results of Batten-1 trial in CLN3 Batten disease patients, showing safety and efficacy of miglustat. Expanded use indicates potential in visual acuity stabilization

Theranexus BBDF Batten-1 Trial CLN3 Batten Disease Miglustat
BRIEF

published on 10/23/2024 at 18:05, 1 year 3 months ago

Theranexus Annonce Sa Trésorerie au 30 Septembre 2024

Trésorerie Maladie De Batten Partenariats Industriels Miglustat Crédit Impôt Recherche
BRIEF

published on 10/23/2024 at 18:05, 1 year 3 months ago

Theranexus Announces Its Cash Position as of September 30, 2024

Treasury Batten Disease Miglustat Research Tax Credit Industrial Partnerships
PRESS RELEASE

published on 10/23/2024 at 18:00, 1 year 3 months ago

THERANEXUS PUBLIE SA POSITION DE TRÉSORERIE AU 30 SEPTEMBRE 2024
Theranexus annonce sa trésorerie au 30 septembre 2024 avec 1,9 M€ disponible, incluant le Crédit Impôt Recherche de 785 K€. Projet d'enregistrement en Europe et phase 3 dans la maladie de Batten

Trésorerie Phase 3 Theranexus Maladies Neurologiques CIR
PRESS RELEASE

published on 10/23/2024 at 18:00, 1 year 3 months ago

THERANEXUS ANNOUNCES ITS CASH POSITION AS OF SEPTEMBER 30, 2024
Theranexus reports €1.9 million cash position as of September 30, 2024, with plans for product registrations and phase 3 trials in rare neurological diseases

Cash Position Biopharmaceutical Theranexus Rare Neurological Diseases Product Registrations
BRIEF

published on 10/17/2024 at 18:05, 1 year 3 months ago

Theranexus s'associe à Synerlab pour une avancée dans le traitement de Niemann-Pick C

Theranexus EMA Synerlab Miglustat Niemann-Pick C
BRIEF

published on 10/17/2024 at 18:05, 1 year 3 months ago

Theranexus partners with Synerlab for a breakthrough in the treatment of Niemann-Pick C

Theranexus EMA Synerlab Miglustat Niemann-Pick C
PRESS RELEASE

published on 10/17/2024 at 18:00, 1 year 3 months ago

THERANEXUS S'ASSOCIE À SYNERLAB POUR PRÉPARER LA COMMERCIALISATION DE SA FORMULATION PÉDIATRIQUE DANS LA MALADIE DE NIEMANN-PICK DE TYPE C
Theranexus et Synerlab annoncent un partenariat pour la production du traitement Mig-OS pour la maladie de Niemann-Pick de type C. Lancement commercial prévu dès 2026

Theranexus EMA Synerlab Mig-OS Maladie De Niemann-Pick De Type C
PRESS RELEASE

published on 10/17/2024 at 18:00, 1 year 3 months ago

THERANEXUS JOINS UP WITH SYNERLAB TO PREPARE THE COMMERCIALIZATION OF ITS PEDIATRIC FORMULATION IN NIEMANN-PICK TYPE C DISEASE
Theranexus partners with Synerlab to produce oral solution of miglustat for Niemann-Pick type C disease, aiming for EMA approval and commercialization by 2026. Novel pediatric formulation Mig-OS provides new therapeutic option for NPC patients

Theranexus Synerlab Miglustat Niemann-Pick Type C Disease EMA Approval

Published on 01/31/2026 at 03:15, 1 day 5 hours ago

Empress Royalty Announces Grant Of Restricted Share Units
Published on 01/31/2026 at 02:20, 1 day 6 hours ago

Boron One Announces First Closing of Financing
Published on 01/31/2026 at 01:40, 1 day 7 hours ago

Star Copper Announces Grant of RSUs, Stock Options and PSUs
Published on 01/31/2026 at 00:00, 1 day 8 hours ago

BE Resources Announces Private Placement
Published on 01/30/2026 at 23:00, 1 day 9 hours ago

Avidian Gold Corp. Announces Director Resignation

View all ACCESSWIRE

Published on 01/31/2026 at 15:54, 16 hours 55 minutes ago

EQS-Adhoc: Wolford AG: Capital increase will not be implemented
Published on 01/31/2026 at 12:25, 20 hours 25 minutes ago

JOHNNIE WALKER TOASTS MUSIC'S BIGGEST WEEKEND WITH THE GO GO HIGHBALL
Published on 01/31/2026 at 02:45, 1 day 6 hours ago

CANADA BACKS NEW DEFENCE, SECURITY AND RESILIENCE BANK
Published on 01/30/2026 at 22:00, 1 day 10 hours ago

Nebius Group N.V. announces date of fourth quarter and full year 2025 results and conference call
Published on 01/30/2026 at 20:10, 1 day 12 hours ago

Cynosure Lutronic Announces Completion of EU MDR Approval and Global Momentum for Mosaic 3D™ Ahead of IMCAS 2026

View all EQS

Published on 01/30/2026 at 18:40, 1 day 14 hours ago

ICADE - Bilan semestriel du contrat de liquidite
Published on 01/30/2026 at 18:01, 1 day 14 hours ago

Emova Group - Résultats annuels 2024/25
Published on 01/30/2026 at 17:45, 1 day 15 hours ago

Schneider Electric launches a capital increase reserved for employees
Published on 01/30/2026 at 17:45, 1 day 15 hours ago

Schneider Electric lance une augmentation de capital réservée aux salariés
Published on 01/30/2026 at 08:30, 2 days ago

Claude Bernard lance Senior+, un assistant IA conçu pour améliorer la prise en charge des patients les plus âgés

View all LES ECHOS COMFI WIRE

News